Ethos Technologies Inc.(LIFE.US)

Last Updated 19:00:00 ET
longbridge loading
Company Encyclopedia
View More
name
Ethos Technologies Inc.
LIFE.US
Ethos Technologies Inc. provides third-party administrator services for insurance policies in United States, India, and Singapore. It offers Ethos, a three-sided technology platform that transforms the buying, selling, and risk management experience of life insurance for consumers, agents, and carriers. It products include term life insurance, whole life insurance policies, and indexed universal life insurance.
--
LIFE.USMarket value -Rank by Market Cap -/-

Valuation analysis

portai
P/E
1Y
3Y
5Y
10Y
P/E
-
Industry Ranking
-/-
  • P/E
  • Price
  • High
  • Median
  • Low
P/B
1Y
3Y
5Y
10Y
P/B
-
Industry Ranking
-/-
  • P/B
  • Price
  • High
  • Median
  • Low
P/S
1Y
3Y
5Y
10Y
P/S
-
Industry Ranking
-/-
  • P/S
  • Price
  • High
  • Median
  • Low
Dividend Yield
1Y
3Y
5Y
10Y
Dividend Yield
-
Industry Ranking
-/-
  • Dividend Yield
  • Price
  • High
  • Median
  • Low

Institutional View & Shareholder

Analyst Ratings

Rating
Percentage
    • Price
      --
    • Highest
      --
    • Lowest
      --
    News
    View More

    aTyr Pharma, Inc. (NASDAQ:ATYR) Sees Significant Drop in Short Interest

    aTyr Pharma, Inc. (NASDAQ:ATYR) experienced a significant decline in short interest, dropping 17.7% to 25,013,857 shares as of December 31. Approximately 26.5% of the company's stock is short sold, with a days-to-cover ratio of 11.1 days. Hedge funds have increased their positions, owning 61.72% of the stock. The company's stock opened at $0.71, with a market cap of $69.44 million. Analysts have a Hold rating on the stock, with an average price target of $23.25.

    Market Beat·
    US
    LIFE
    -12.11%
    Market Beat·
    US
    LIFE
    -12.11%

    Johnson Fistel investigates potential derivative claims for aTyr Pharma Inc. (NASDAQ: ATYR) over alleged fiduciary breaches in Phase 3 EFZO-FIT trial disclosures.

    Investigations are being carried out by Johnson Fistel, PLLP in San Diego starting December 15, 2025, regarding derivative claims associated with aTyr Pharma, Inc. (NASDAQ: ATYR) involving suspected breaches of fiduciary duties related to the Phase 3 EFZO-FIT clinical trial disclosures. The class action in question pertains to...

    Unusual Whales·
    US
    LIFE
    -12.11%
    Unusual Whales·
    US
    LIFE
    -12.11%

    20:59 ET ATYR Deadline: ATYR Investors with Losses Have Opportunity to Lead aTyr Pharma, Inc. Securities Fraud Lawsuit

    Rosen Law Firm announces a class action lawsuit against aTyr Pharma, Inc. for securities fraud. Investors who purchased stock between January 16, 2025, and September 12, 2025, may join the lawsuit. The deadline to serve as lead plaintiff is December 8, 2025. Rosen Law Firm, known for its success in securities class actions, encourages investors to choose experienced counsel. The lawsuit claims aTyr Pharma made false statements about the efficacy of Efzofitimod, causing investor losses.

    prnewswire·
    US
    LIFE
    -12.11%
    prnewswire·
    US
    LIFE
    -12.11%

    Pomerantz LLP Notifies Investors of Class Action Filing Against aTyr Pharma, Inc. – ATYR

    Pomerantz LLP has filed a class action lawsuit against aTyr Pharma, Inc. for alleged securities fraud following the failure of the EFZO-FIT study. The study's disappointing results led to an 83.17% drop in aTyr's stock price. Investors have until December 8, 2025, to join the lawsuit as Lead Plaintiff. Pomerantz LLP is renowned for its expertise in securities class actions.

    Acceswire·
    US
    LIFE
    -12.11%
    Acceswire·
    US
    LIFE
    -12.11%

    03:25 ET aTyr Pharma, Inc. Investigated for Securities Fraud Violations - Contact the DJS Law Group to Discuss Your Rights - ATYR

    DJS Law Group is investigating aTyr Pharma, Inc. for securities fraud violations. The investigation focuses on whether aTyr issued misleading statements or failed to disclose important information. Following news of a failed drug study, aTyr's shares dropped over 81%. Shareholders who suffered losses are encouraged to contact DJS Law Group. The firm specializes in securities class actions and corporate governance litigation.

    prnewswire·
    US
    LIFE
    -12.11%
    prnewswire·
    US
    LIFE
    -12.11%
    © 2026 Longbridge｜Disclaimer